US Stock MarketDetailed Quotes

ALGS Aligos Therapeutics

Watchlist
  • 8.250
  • -0.870-9.54%
Close Mar 31 16:00 ET
  • 8.170
  • -0.080-0.97%
Post 17:18 ET
50.44MMarket Cap-0.39P/E (TTM)

Aligos Therapeutics Key Stats

Aligos Therapeutics Q4 2024 Earnings Date

Currency:USDMar 10, 2025

Estimate
(YoY)
Actual
(YoY)
Vs Estimate
(% Chg)
Revenue
433.33K
629.00K
+195.67K
Beat Est.
-78.43%
-76.54%
+45.15%
EPS
-2.50
-13.08
-10.58
Miss Est.
+54.61%
-40.87%
-423.91%
Buy

Mar 11, 2025

Aligos Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 3 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q2-- / 333.330K--
--2025/Q1-- / 333.330K--
Mar 10, 20252024/Q4629.000K / 433.330K--
Nov 6, 20242024/Q31.269M / 333.330K--
Aug 6, 20242024/Q21.061M / 0.000--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q2-- / 333.330K--
--2025/Q1-- / 333.330K--
Mar 10, 20252024/Q4629.000K / 433.330K--
Nov 6, 20242024/Q31.269M / 333.330K--
Aug 6, 20242024/Q21.061M / 0.000--

Unlock Free Earnings Estimates

Aligos Therapeutics Earnings Reports

Read more

Market Insights
U.S Tech Companies U.S Tech Companies

U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.

Analysis

Analyst Rating

Updated: Mar 11, 2025

Buy

  • Buy

    100.00%
  • Hold

    0.00%
  • Sell

    0.00%

Price Target

No Data